2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica

(2015) Christian Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis

(2014) Sofia Ramiro et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

(2013) N Duru et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

(2013) Josef S Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Effective Control of Polymyalgia Rheumatica With Tocilizumab

(2013) Abdulrahman Al Rashidi et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Tocilizumab for polymyalgia rheumatica: Report of two cases and review of the literature

(2013) Pierluigi Macchioni et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series

(2013) Andreas P. Diamantopoulos et al.   Biomed Research International

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2012) Bhaskar Dasgupta et al.   ANNALS OF THE RHEUMATIC DISEASES

2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

(2012) Bhaskar Dasgupta et al.   ARTHRITIS AND RHEUMATISM

Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series

(2012) T. Adizie et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)

(2012) Jung Hwa Lee et al.   RHEUMATOLOGY INTERNATIONAL

Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendations

(2011) J. L. Brożek et al.   ALLERGY

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies

(2011) L Gossec et al.   ANNALS OF THE RHEUMATIC DISEASES

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Clinical Characteristics of Patients with Remitting Seronegative Symmetrical Synovitis with Pitting Edema Compared to Patients with Pure Polymyalgia Rheumatica

(2011) M. KIMURA et al.   JOURNAL OF RHEUMATOLOGY

Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus

(2010) C. Dejaco et al.   ANNALS OF THE RHEUMATIC DISEASES

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

(2010) M. C. van der Goes et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

Treating rheumatoid arthritis to target: recommendations of an international task force

(2010) J. S. Smolen et al.   ANNALS OF THE RHEUMATIC DISEASES

GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology

(2010) Gordon H. Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica

(2010) K. HAGIHARA et al.   JOURNAL OF RHEUMATOLOGY

Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study

(2010) S. L. Mackie et al.   RHEUMATOLOGY

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies

(2009) J. L. Brożek et al.   ALLERGY

Grading quality of evidence and strength of recommendations in clinical practice guidelines

(2009) J. L. Brożek et al.   ALLERGY

Treatment of Polymyalgia Rheumatica

(2009) José Hernández-Rodríguez   ARCHIVES OF INTERNAL MEDICINE

The epidemiology of glucocorticoid-associated adverse events

(2009) Allyson K McDonough et al.   CURRENT OPINION IN RHEUMATOLOGY

BSR and BHPR guidelines for the management of polymyalgia rheumatica

(2009) B. Dasgupta et al.   RHEUMATOLOGY

Polymyalgia rheumatica in primary care: a cohort study of the diagnostic criteria and outcome

(2008) K. Barraclough et al.   FAMILY PRACTICE